Literature DB >> 6861655

[Local fibrinolysis therapy in subtotal stenosis of the median cerebral artery].

H Zeumer, E B Ringelstein, M Hassel, K Poeck.   

Abstract

In a 60-year-old female patient with clinical symptoms of progressive left-sided apoplexia and subtotal stenosis of the middle cerebral artery local fibrinolysis via a floating balloon catheter was successfully used for recanalisation of the vessel leading to marked clinical improvement.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6861655     DOI: 10.1055/s-2008-1069701

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  7 in total

Review 1.  [Intra-arterial thrombolysis of the middle cerebral artery: an overview].

Authors:  T Struffert; S Ruffing; W Reith
Journal:  Radiologe       Date:  2005-05       Impact factor: 0.635

2.  Vascular recanalizing techniques in interventional neuroradiology.

Authors:  H Zeumer
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

3.  Interventional neuroradiology. State of the art and perspectives.

Authors:  K Poeck
Journal:  J Neurol       Date:  1986-11       Impact factor: 4.849

4.  Local intraarterial fibrinolytic therapy in inaccessible internal carotid occlusion.

Authors:  H Zeumer; R Hündgen; A Ferbert; E B Ringelstein
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

Review 5.  Thrombolytic therapy. From myocardial to cerebral infarction. The MAST-I Group. Multicentre Acute Stroke Trial.

Authors:  L Candelise; C Roncaglioni; E Aritzu; A Ciccone; A P Maggioni
Journal:  Ital J Neurol Sci       Date:  1996-02

6.  Metastatic brain tumour and fibrinopeptides.

Authors:  K Yumitori; H Handa; T Teraura; J Yamashita; K Yamamura
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

7.  Cerebral ischemia in children and young adults.

Authors:  R Karnik; A Valentin; H P Ammerer; C Stöllberger; G Perneczky; J Slany; H Brenner
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.